Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Budgets and health technology assessment threaten German R&D efforts

This article was originally published in Clinica

Executive Summary

Budget setting and the potential adoption of health technology assessment (HTA) are the two principal factors threatening the availability of medical devices in Germany. That was the consensus emerging from a press seminar in Berlin last week, entitled "Medical technology of the future - the future of medical technology," which was organised by BVMed, the German medical devices industry association, and sought to examine the future role of innovative medical devices in the German health system.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT075013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel